Biopharmaceutical Contract Manufacturing Market is estimated to be worth USD 13.9 billion in 2030
Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages
Continue reading